American Board of Internal Medicine home page

Initial Certification indicates that physicians have met rigorous standards through intensive study, accredited training and evaluation and that they have the clinical judgment, skills and attitudes essential for the delivery of excellent patient care.

MOC is a professionally determined standard that attests that an internist is staying current in knowledge and practice throughout his/her career.

For more than 75 years, Certification by ABIM has stood for the highest standard in internal medicine and its 20 subspecialties.

Cardiovascular Board Adult Congenital Heart Disease Exam Committee

Curt J. Daniels, MD, Chair

Dr. Daniels is the Dottie Dohan Shepard Endowed Chair and Professor of Clinical Internal Medicine and Pediatrics in the Division of Cardiology at The Ohio State University and the Division of Pediatric Cardiology at Nationwide Children's Hospital. He is the Director of the Columbus Ohio Adult Congenital Heart Disease and Pulmonary Hypertension Programs (COACH) at both facilities. Dr. Daniels is board certified in both pediatric cardiology and internal medicine cardiology.

Dr. Daniels serves on the Adult Congenital/Pediatric Cardiology Council and is the Chair of the ACHD Working Group of the American College of Cardiology. In addition, Dr. Daniels serves as Chair of the Adult Congenital Heart Association Medical Advisory Board, and is Chair of the ACHA ACHD Program Accreditation Committee. Dr. Daniels is committed to education and has trained fellows in ACHD since 2001. The fellowship became formalized as a 24-month training program under the Schooler ACHD Fellowship in 2010. He has also worked to develop a subspecialty board certification in ACHD and currently serves as the Chair of the ABIM ACHD Subspecialty Board Certification Committee.

For the past eight years Dr. Daniels has led a bi-monthly regional patient education lecture series for ACHD patients and has led the effort to provide a personalized electronic medical record for all patients followed in the ACHD program. Dr. Daniels has designed, implemented and successfully completed multiple ACHD research studies and presented his research nationally and internationally. In collaboration with colleagues from The Ohio State University and Nationwide Children's Heart Center, he has mentored fellows training thru the NIH T32 Training Grant entitled “Training in Congenital Heart Disease.” In 2011 Dr. Daniels was elected President of the International Society for ACHD and plans to develop Global Health Initiatives for ACHD. In 2014, he was selected as Co-Chair of the ACC/AHA ACHD Care Guidelines.

Dr. Daniels is a graduate of the Ohio State University College of Medicine. He completed his residency and fellowship at The Ohio State University Medical Center and Nationwide Children's Hospital.

As of January 2017, Dr. Daniels reported the following external relationships:

Funding for clinical trial expenses and staff, paid to The Ohio State University, from the following companies:

  • Actelion Pharmaceuticals Ltd., providing funding for a clinical trial to assess the efficacy, safety and tolerability of macitentan in subjects with Eisenmenger syndrome.
  • Pfizer, providing funding for a multi-center clinical trial on pulmonary hypertension with children with tadalafil, a pharmacokinetic trial, and an open-label trial.

Dr. Daniels reported continuing medical education supported by the following, with compensation for travel expenses and honoraria:

  • Penn State College of Medicine, for pulmonary hypertension lectures to community hospitals.

Dr. Daniels serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Adult Congenital Heart Association, Chair of Medical Advisory Board and Board of Directors, without compensation.
  • International Society for Adult Congenital Heart Disease, Past President and current member of Executive Committee, without compensation.

Jamil A. Aboulhosn, MD

Dr. Aboulhosn, a board certified cardiologist, is Associate Professor of Medicine and Pediatrics in the Division of Cardiology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). He is the Director of the Ahmanson/UCLA Adult Congenital Heart Disease Center. He was awarded the Streisand American Heart Association Chair in Cardiology in 2014.

Previously, Dr. Aboulhosn served as the Director of Clinical Research at the Ahmanson/UCLA Adult Congenital Heart Disease Center and the Director of the Westwood Heart Center Non-Invasive Imaging Laboratory. From 2009 to 2012, he served as the Director of Adult Congenital Heart Disease at the Children's Heart Center Nevada.

Dr. Aboulhosn is the current Chairman of the Global Research Working Group for the International Society for Adult Congenital Heart Disease. He is also the Vice-Chairman of the Adult Congenital Heart Association's Medical Advisory Board. He is a member of the American Board of Internal Medicine Cardiovascular Board Adult Congenital Heart Disease Exam Committee. He is also an active member and fellow of the Society for Cardiac Angiography and Interventions and the American College of Cardiology. Dr. Aboulhosn is also a founding member and former President and Secretary of the Association for Adult Research in Congenital Cardiology. He serves on the editorial board of the American Journal of Cardiology and is a guest editor for Circulation.

Dr. Aboulhosn received his bachelor's degree in biomedical sciences from the University of California, Riverside and his medical degree from UCLA. He completed his house-staff and adult cardiology training at Harbor-UCLA Medical Center followed by a fellowship in adult congenital heart disease at UCLA.

As of January 2017, Dr. Aboulhosn reported the following external relationships:

Funding for clinical trial expenses and staff, paid to UCLA School of Medicine, from the following companies:

  • Actelion Pharmaceuticals, funding a study of macitentan in Eisenmenger syndrome.
  • Edwards Lifesciences, funding a study of the safety and effectiveness of pulmonic transcatheter heart valve implantation in patients requiring treatment for moderate or severe pulmonary regurgitation.

Attendance at investigators' meetings, with compensation for travel expenses from the following company:

  • Actelion Pharmaceuticals, for planning of a clinical trial on macitentan use in Fontan patients.

Post-marketing clinical research, with funding provided to UCLA School of Medicine, from the following company:

  • St. Jude, post-marketing study of erosions with the AMPLATZER® septal occluder device.

Work as an author or editor for following company, with compensation as listed:

  • Elsevier, receiving royalties for co-editing the textbook, Congenital Heart Disease in Adults, 3rd edition

Dr. Aboulhosn serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Adult Congenital Heart Association, Vice-Chairman of Medical Advisory Board, without compensation.
  • Edwards Lifesciences: Dr. Aboulhosn serves as a proctor for other physicians in the use of the Edwards Sapien XT valve.

Naser M. Ammash, MD

Dr. Ammash is board certified in Internal Medicine and Cardiovascular Disease. He is a Professor of Medicine, Mayo Clinic College of Medicine, and a Consultant in Cardiovascular Diseases at the Mayo Clinic. He is also the Vice Chair for Clinical Practice, for the Division of Cardiovascular Diseases at Mayo Clinic.

Dr. Ammash is the past co-Director of the Echocardiography Laboratory with special interests in congenital, interventional and intraoperative echocardiography. His main clinical interest is the care of the adults with congenital heart disease, diseases of the aorta as well as those with heart disease during pregnancy.

Dr. Ammash currently serves on the Cardiovascular Board Adult Congenital Heart Disease Exam Committee of the American Board of Internal Medicine and enjoys providing continuing education in his fields of interests.

He received his medical degree and completed his internship in internal medicine from the American University of Beirut. He completed special fellowships in echocardiography and adult congenital heart disease at the Mayo Graduate School of Medicine, Mayo Clinic College of Medicine.

As of January 2017, Dr. Ammash reported the following external relationships:

Work as an author or editor for following company, with compensation as listed:

  • UpToDate, receiving compensation for authorship of chapters on ventricular septal defects, atrial septal defects, patent foramen ovale and restrictive cardiomyopathy.

Dr. Ammash serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • Adult Congenital Heart Association, Member of Medical Advisory Board, without compensation.

Anne M. Dubin, MD

Dr. Dubin is the Director of the Pediatric Arrhythmia Service at Lucile Packard Children's Hospital at Stanford, and is a Professor of Pediatrics at Stanford University. She is board certified in both Pediatric Cardiology and Adult Congenital Heart Disease. Dr. Dubin has been a member of the pediatric cardiology division at Stanford since 1995.

She has served on the National Heart, Lung, and Blood Institute (NHLBI) Clinical and Integrative Cardiovascular Science Study Section as well as the NHLBI Electromagnetic Devices Study Section. Dr. Dubin is a member of the Scientific and Clinical Documents Committee for Heart Rhythm Society and serves on the American Board of Internal Medicine Cardiovascular Board Adult Congenital Heart Disease Exam Committee.

She received a degree in biochemistry from Mount Holyoke College and her medical degree from University of Rochester School of Medicine and Dentistry. She completed internship and residency at Babies Hospital, Columbia-Presbyterian Medical Center (now Morgan Stanley Children's Hospital), and her pediatric cardiology fellowship at Children's Hospital of Philadelphia and Yale Medical Center. Dr. Dubin also completed an adult electrophysiology fellowship at Yale Medical Center.

As of January 2017, Dr. Dubin reported the following external relationships:

Work as an author or editor for following company, with compensation as listed:

  • UpToDate, receiving compensation for authorship of two articles on pediatric electrophysiology.

Gerard R. Martin, MD

Dr. Martin is a pediatric cardiologist and Medical Director for Global Services at Children's National Health System, located in Washington, D.C. He has been in practice at Children's National Health System since 1986. Dr. Martin is a Professor of Pediatrics, with tenure, at the George Washington University School of Medicine and served as the Chief of Cardiology from 1997 to 2009. Dr. Martin developed the Children's National Heart Institute and served as a Senior Vice President for 15 years. He was named the C. Richard Beyda Professor of Cardiology in 2007.

Dr. Martin is board certified in Pediatric Cardiology by the American Board of Pediatrics. He is a fellow of the American Academy of Pediatrics and the American College of Cardiology, and a member of the Society for Pediatric Research and the American Board of Pediatrics. He has served or is currently serving on the Subboard of Pediatric Cardiology, American Board of Pediatrics; as Chairman of the Section Adult Congenital and Pediatric Cardiology, American College of Cardiology; and, on the Board of Trustees, American College of Cardiology. He is currently a member of the American Board of Internal Medicine Cardiovascular Board Adult Congenital Heart Disease Exam Committee.

Dr. Martin has published more than 125 peer reviewed manuscripts, book chapters and invited publications and has presented abstracts at numerous national and international meetings. He is an invited lecturer who has traveled to more than 100 hospitals and universities within the U.S. as well as around the world. Additionally, Dr. Martin has been a volunteer on medical missions to Third World countries. He has served in a consultant role within the United States as well as in South America, Asia and the Middle East. His current research interests are focused on screening for critical congenital heart disease, quality improvement in congenital heart disease and population health and health promotion.

Dr. Martin was educated at Syracuse University and the State University of New York, Upstate School of Medicine. After a residency at Brown University and the Rhode Island Hospital, he received his training in pediatric cardiology at the Cardiovascular Research Institute at the University of California, San Francisco.

As of January 2017, Dr. Martin reported the following external relationships:

Dr. Martin serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • Pediatric Congenital Heart Association, Medical Advisory Board Member, without compensation.

Arwa Saidi, MB, BCh, MEd

Dr. Saidi is an adult congenital cardiologist and is Director of the adult congenital heart disease program at the University of Florida in Gainesville, Florida. She is board certified in Pediatric Cardiology, Internal Medicine and Adult Congenital Heart Disease.

Dr. Saidi joined the faculty at the University of Florida in 2003. In 2015, Dr. Saidi served as Director of the American College of Cardiology (ACC) Adult Congenital Heart Disease (ACHD) Self-Assessment Product and has previously served as topic coordinator for the congenital cardiology sessions of the ACC 12. She is a Writing Committee Member of the ACC/American Heart Association Guidelines for the Management of Adults with Congenital Heart Disease (2014 to 2015) and the Pediatric Cardiology Training Guidelines as the American Academy of Pediatrics' representative for ACHD section (2014 to 2015). Dr. Saidi is a course developer and instructor for the Health Care Transition Course at the University of Florida College of Education (2010 to present).

Dr. Saidi is a member of the American Board of Internal Medicine Cardiovascular Board Adult Congenital Heart Disease Exam Committee. She has been a member of the Adult Congenital Heart Association Medical Advisory Board and currently serves on the Board of Directors. She has received the University of Florida Exemplary Teacher Award (2011, 2015) and Outstanding Achievement for Medical Student Education (2009).

Dr. Saidi received her medical degree from the Royal College of Surgeons in Dublin, Ireland, and completed her internal medicine/pediatrics and pediatric cardiology fellowship training at Baylor College of Medicine, Houston, Texas. She completed her master of education degree at the University of Florida College of Education in 2012.

As of January 2017, Dr. Saidi reported the following external relationships:

Dr. Saidi serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Adult Congenital Heart Association, Medical Advisory Board and Board of Directors, receiving reimbursement for travel expenses.

Karen K. Stout, MD

Dr. Stout is a board certified cardiologist and is Director of the Adult Congenital Heart Disease Program and Director of the Adult Congenital Heart Disease (ACHD) Fellowship at the University of Washington Medical Center and Seattle Children's Hospital. She is a Professor of Cardiology in Medicine and Pediatrics at the University of Washington. Her academic interests are adult congenital heart disease, pregnancy and heart disease and echocardiography.

Dr. Stout is a member of the American Board of Internal Medicine (ABIM) Cardiovascular Board Adult Congenital Heart Disease Exam Committee and the ABIM Cardiovascular Board. She is Chair of the 2015 American College of Cardiology (ACC)/American Heart Association (AHA) Care of Adults with Congenital Heart Disease Guidelines Writing Committee and has chaired or been a member of several AHA scientific statements regarding congenital heart disease. She is a member of the ACC Adult Congenital and Pediatric Cardiology Committee and is Chair of the AHA ACHD Committee.

Dr. Stout earned her medical degree from the University of Arizona. She completed internal medicine residency and chief residency at Oregon Health and Sciences University and Cardiology fellowship at the University of Washington. She completed a congenital heart disease fellowship at Seattle Children's Hospital.

As of January 2017, Dr. Stout reported the following external relationships:

Work as an author or editor for following companies, with compensation as listed:

  • Elsevier, receiving royalties for a textbook that she edited.
  • UpToDate, receiving compensation for authorship.

Dr. Stout serves in significant roles with the following organizations, receiving compensation as listed:

  • American College of Cardiology, Member of Adult Congenital and Pediatric Cardiology Council, without compensation.
  • American Congenital Heart Association, Medical Advisory Board, without compensation.
  • American Heart Association, Puget Sound Chapter Board of Directors, without compensation.